Collaboration to validate next-generation tests for detection of primary and recurrent/metastatic cancer and personalized treatment response prediction. Partnership aims to enhance precision oncology through advanced novel biomarker-driven diagnostics. HealthCare Global Enterprises Limited (HCG), India’s leading provider of cancer care announced a research collaboration with Trucan
Community Gathers in Support of Early Detection and Screening with 180 Women Riders Leading the Charge In observance of Breast Cancer Awareness Month, HCG Cancer Centre Bengaluru successfully hosted the ‘Pink Women’s Bikeathon 2024,’ a 10-kilometer all women bike rally aimed at raising awareness for breast
HCG Cancer Centre Bengaluru is proud to announce the launch of the CyberKnife S7 System, a fully automated, AI-driven treatment delivery system with real-time motion adaptation, marking a significant advancement in the treatment of both cancerous and non-cancerous tumors. The system was unveiled by Dr.
Revenue for Q4 FY24 of INR 4,946 Million, a growth of 12% (y-o-y) and for FY24 of INR 19,121 Million, a growth of 13% (y-o-y) EBITDA for Q4 FY24 of INR 941 Million, a growth of 21% (y-o-y) and EBITDA for FY24 of INR 3,374 Million,
HCG Abdur Razzaque Ansari Cancer Hospital Ranchi announced the launch of Jharkhand’s most advanced Elekta Versa HD Platform, a versatile, all-in-one system that is capable of delivering a wide variety of external radiation therapy modalities for a broad spectrum of cancers. The media was briefed by
Envisioned to drive a new standard of cancer care, Triesta Sciences, a Unit of HealthCare Global Enterprises Limited (HCG Cancer Hospital) Bengaluru on the occasion of completion of comprehensive genomic profiling (CGP) of 1000+ cancer patients hosted a symposium on the therapeutic and prognostics utility
HCG EKO Cancer Centre, along with biker group, Eastern Bulls, organised a bike rally which was followed by a blood donation camp and a day-long entertainment event to brighten up the day for children affected by Thalassemia HCG EKO Cancer Centre Kolkata recently organised an inspiring
Begins to install Da Vinci X systems in Mumbai, Kolkata & few other cities HealthCare Global Enterprises Limited (HCG), the largest cancer care network in India, collaborates with Intuitive to augment the accessibility of new-age surgical technology and robotic-assisted surgery (RAS), across India, including non-metro
Revenue for Q2 FY22 of INR 4,200 Million, a growth of 19.3% (y-o-y) and 2.9% (q-o-q) Revenue for H1 FY23 of INR 8281 Million, a growth of 22.7% (y-o-y) EBITDA for Q2 FY23 of INR 810 Million, a growth of 28.0% (y-o-y) and 7.2% (q-o-q) EBITDA for
